Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy

<div class="floats-full-page floats-full-page-other"><h2>Table 7</h2><div class="floats-full-page-caption">Multivariate prognostic analysis.</div><div class="floats-full-page-content"><table class="table-group" id="tab7"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr /></td></tr><tr class="thead"><td align="left" rowspan="2">Prognostic factors</td><td align="center" colspan="2">LC</td><td align="center" colspan="2">OS</td></tr><tr class="thead"><td align="center">HR</td><td align="center"><span style="width: 8.35923ptpx;"><svg height="8.80632pt" id="M28" version="1.1" viewbox="0 -8.80632 8.35923 8.80632" width="8.35923pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M600 480C600 590 528 650 384 650H143L137 622C222 614 225 607 210 531L130 127C113 41 106 36 23 28L17 0H294L300 28C204 36 195 42 212 127L243 284L314 263C327 263 339 263 352 264C465 271 600 337 600 480ZM508 481C508 351 402 304 329 304C289 304 265 311 250 317L295 559C302 594 310 606 323 611C335 616 350 619 367 619C455 619 508 573 508 481Z" id="g113-81"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="617" vert-adv-y="617"></glyph.data></g></svg></span></td><td align="center">HR</td><td align="center"><span style="width: 8.35923ptpx;"><svg height="8.80632pt" id="M29" version="1.1" viewbox="0 -8.80632 8.35923 8.80632" width="8.35923pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M600 480C600 590 528 650 384 650H143L137 622C222 614 225 607 210 531L130 127C113 41 106 36 23 28L17 0H294L300 28C204 36 195 42 212 127L243 284L314 263C327 263 339 263 352 264C465 271 600 337 600 480ZM508 481C508 351 402 304 329 304C289 304 265 311 250 317L295 559C302 594 310 606 323 611C335 616 350 619 367 619C455 619 508 573 508 481Z" id="g113-81"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="617" vert-adv-y="617"></glyph.data></g></svg></span></td></tr><tr><td class="thead-hr" colspan="5"><hr /></td></tr><tr><td align="left">T stage</td><td align="center">4.592</td><td align="center">&lt;0.001</td><td align="center">0.955</td><td align="center">0.061</td></tr><tr><td align="left">N stage</td><td align="center">0.662      </td><td align="center">0.098</td><td align="center">5.258</td><td align="center">&lt;0.001</td></tr><tr><td align="left">GTVnx volume</td><td align="center">1.825                       </td><td align="center">0.064</td><td align="center">3.846</td><td align="center">&lt;0.001</td></tr><tr><td align="left">Radiotherapy interruption </td><td align="center">5.481                     </td><td align="center">&lt;0.001</td><td align="center">4.233</td><td align="center">&lt;0.001</td></tr><tr><td align="left">HGB</td><td align="center">0.339                       </td><td align="center">0.463</td><td align="center">1.905</td><td align="center">0.002</td></tr><tr><td align="left">Percentage of weight loss</td><td align="center">0.229                       </td><td align="center">0.621</td><td align="center">1.018</td><td align="center">0.033</td></tr><tr><td align="left">Chemo. or not</td><td align="center">0.683                      </td><td align="center">0.221</td><td align="center">4.353</td><td align="center">&lt;0.001</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr" /></td></tr></table></td></tr><tr class="table-fn"><td>HGB: hemoglobin; LC: local-regional control rates; OS: overall survival rate; HR: hazards ratio.<br /></td></tr></table></div></div>

Table 7 | Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy

title

Table 7: Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy

description

Table 7

About this journal

<p><em>BioMed Research International</em> publishes original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.</p>


Journal profile

Meet the editorial board

<p><em>BioMed Research International</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.